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The aetiology of obesity has been attributed to several factors (environmental, dietary, lifestyle, host, and genetic factors); however
none of these fully explain the increase in the prevalence of obesity worldwide. Gut microbiota located at the interface of host and
environment in the gut are a new area of research being explored to explain the excess accumulation of energy in obese individuals
and may be a potential target for therapeutic manipulation to reduce host energy storage. Several mechanisms have been suggested
to explain the role of gut microbiota in the aetiology of obesity such as short chain fatty acid production, stimulation of hormones,
chronic low-grade inflammation, lipoprotein and bile acid metabolism, and increased endocannabinoid receptor system tone.
However, evidence from animal and human studies clearly indicates controversies in determining the cause or effect relationship
between the gut microbiota and obesity. Metagenomics based studies indicate that functionality rather than the composition of
gut microbiota may be important. Further mechanistic studies controlling for environmental and epigenetic factors are therefore
required to help unravel obesity pathogenesis.
1. Introduction
Initial Evidence of the Role of Gut Microbiota in Obesity.
The worldwide increase in obesity has prompted researchers
to investigate its aetiology which is multifactorial, involving
environmental, dietary, lifestyle, genetic, and pathological
factors. Although the gut microbiota were already estab-
lished as a metabolic organ that could ferment nondi-
gestible dietary components (particularly nondigested carbo-
hydrates) to generate short chain fatty acids (SCFA), their role
as a significant environmental factor affecting host adiposity
through an integrated host signalling pathway was explored
in 2004 by Ba¨ckhed and colleagues [1]. This breakthrough
evidence suggested that the gut microbiota induced adiposity
by stimulating hepatic de novo lipogenesis and triglyceride
storage through carbohydrate response element binding pro-
tein (ChREBP) and sterol response element binding protein
1 (SREBP1) and by suppressing fasting induced adipocyte
factor (fiaf ) which is an inhibitor of adipocyte lipoprotein
lipase [1].The same group proposed that this intestinal “high-
efficiency bioreactor” in certain individuals might promote
energy storage (obesity), whereas a low-efficiency reactor
would promote leanness due to lesser energy harvest from
carbohydrate fermentation [2]. Differences in the gut micro-
biota between obese and lean people were therefore worthy
of further exploration.
Subsequent studies conducted by the same group sug-
gested that although gut microbiota communities were
shared between mothers and offspring regardless of ob geno-
type in genetically obese leptin deficient C57BL/6J ob/obmice
and lean mice (ob/+ and +/+ wild-type siblings) fed similar
polysaccharide rich diets, the ob/obmice had reduced relative
abundance of Bacteroidetes (by 50%) and a proportional
increase in Firmicutes regardless of kinship [3]. A higher
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Firmicutes to Bacteroidetes ratio was therefore suggested
to be associated with increased energy harvest from food
facilitated by the gut microbiota. However, no evidence was
presented to show increased expression of genes related to
bacterial metabolic activity and how this could be affected by
diet and lifestyle norwhether these changes could also be seen
in humans.
Turnbaugh et al. (2006) used whole genome shotgun
metagenomic and microbiota transplantation studies to
investigate the mechanisms [4]. They observed a high Firmi-
cutes rich microbiome in ob/ob mice clustered together (in
nonmetric multidimensional scale plot), richer in enzymes
for degradation of polysaccharides, higher faecal acetate
and butyrate, and less stool energy loss than in lean mice.
Transplantation of gut microbiota from ob/ob mice or lean
mice to germ-free mice resulted in obese (high Firmicutes)
or lean (high Bacteroidetes) gutmicrobiome in the recipients.
Obese microbiome recipients had higher percentage body fat
despite similar food intake.
In a human study [5], obese adults were randomised
onto fat or carbohydrate restricted diets and followed up
for one year. Despite marked interpersonal variations in
gut microbiota diversity, obese people had a lower relative
abundance of Bacteroidetes and a higher relative abundance
of Firmicutes before the restricted calorie intake. However,
over the period of follow-up, the relative abundance of
Bacteroidetes significantly increased while that of Firmicutes
significantly reduced. Increased Bacteroidetes was signifi-
cantly positively correlated with percentage weight loss and
not the caloric content of diet [5]. This suggested that the gut
microbiota restructured, changing their metabolic priorities
to support coexistence in a changed environment. However,
this study did not explore the same relationship in a parallel
lean group to see whether the lean phenotype had the same
response to dietary intervention.
Further evidence suggested the presence of the gut
microbiota was necessary for development of obesity as
germ-free mice were resistant to obesity even when they
consumed more calories from normal chow or a high fat
Western-type diet comparedwithCONVmice [13]. However,
this idea was challenged in a later study by Fleissner et al.
(2010) [14] who found that germ-free mice on a high fat
diet gained significantly more weight and body fat and had
less energy expenditure than lean CONV mice. Addition-
ally, intestinal fiaf increased in HF and WD fed GF mice
compared to CONVmice but not in the systemic circulation
[14].
Several possible mechanisms were proposed to explain
the impact of structural and functional differences in gut
microbiota in lean and obese individuals that may contribute
to host adiposity and whether an obese phenotype is trans-
missible by transplantation of gut microbiota. However, most
of these studies were conducted in experimental animals
which exhibited different anatomical, physiological, and bac-
terial colonisation patterns from humans. Several human
and animal based studies have now revealed controversial
evidence attributing differences in gut microbiota to the
differences in diet [15–17] while others suggested no such
association [18].
2. Proposed Mechanisms for the Role of Gut
Microbiota in Obesity
The gut microbiota can be regarded as a “microbial organ”
contributing to a variety of host metabolic processes from
digestion to modulation of gene expression. The differences
in gut microbiota between lean and obese animals or human
subjects suggest a link between gut microbiota and energy
homeostasis although there is still some debate as to whether
these differences are causally related to an obese or lean
phenotype. Various mechanisms have been suggested to link
gut microbiota with obesity-genesis and other metabolic
disorders (Table 1). However, it is still unclear how these
mechanisms interact to influence the overall metabolic status
of an individual.
2.1. Energy Harvest from Diet (Short Chain Fatty Acids).
Dietary polysaccharides and proteins that escape digestion
in the small intestine are fermented in the colon by the
gut microbiota into SCFA mainly acetate propionate and
butyrate. The amount of energy harvested is hypothesised to
be influenced by the composition of the gut microbiota [2]. It
has been estimated that up to 10%of daily energy requirement
and up to 70% of energy for cellular respiration for the
colonic epithelium may be derived from SCFA. Chronic
excess energy harvest may cause long term increased fat
accumulation in the body [72].
To a greater extent, there is a general agreement from
many studies that the obese phenotype is associated with
excess SCFA in caecal and faecal samples in animal and
human studies compared with the nonobese (Table 2).
However, there is considerable disagreement and controversy
over the population of the gut microbiota that may be
associated with increased caecal or faecal SCFA measured
(Table 3). Whether increased SCFA production results in
increased energy harvest from the diet in obese phenotypes
depends on several factors such as substrate availability, gut
transit, mucosal absorption, gut health, production by the
gutmicrobiota, and symbiotic relationships between different
groups of gut microbiota [66]. Based on the equation derived
by Livesey (1990), approximately 50% (2 kcal/g) of the energy
derived from glucose is available after fermentation. The
net amount of energy derived will therefore vary depending
upon the amount of indigestible carbohydrate available for
fermentation [73].
The obese phenotype in animals is associated with higher
total caecal SCFA, acetate, and butyrate and higher expression
of bacterial genes responsible for polysaccharide metabolism
[4]. Increased efficiency in production of SCFA in obesity
might also result from crosstalk between different species and
genera to maintain their growth and population. Absorption
of these SCFA, coupledwith other lifestyle and environmental
factors may result in excess energy storage and obesity. It is
not clear whether this is an effect of substrate (i.e., carbohy-
drates) or the population of specific gutmicrobiota associated
with increased SCFA production, absorption, and storage in
adipose tissues and liver. The results are largely confounded
by the study settings, lifestyle, and environmental factors of
the study subjects.
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Table 1: Suggested mechanisms for the role of gut microbiota in the aetiology of obesity.
Proposed mechanism Mediators Source ofmediators Target tissues/organs Local/systemic effects
Metabolic
Increased production of









Muscle fatty acid oxidation
[1] ↓ AMP kinase Small intestine Muscle, liver
↓muscle fatty acid
oxidation

















system tone [10, 20] Bacterial LPS Ileum, colon
Stomach, small and
large intestine
↑ gut permeability and ↓
apelin and APJ mRNA
expression
Hormonal
Suppression of Fiaf [1] Colonic L-cells Colon Adipose tissue ↑ lipolysis, ↓muscle fattyacids oxidation
↑ PYY [21] Satiety centre Ileum, colon Hypothalamus
↓ appetite, ↓ gastric
motility, and ↓ gut
emptying
Expression of G protein
coupled receptors 41 and 43
(GPR41 and GPR43) [22]
SCFA (acting as a
ligand)
Colon, distal
ileum, and rectum Liver, brain
↑ peptide YY (PYY), ↑ de
novo hepatic lipogenesis
AMP: adenosinemonophosphate, ChREBP: carbohydrate response element binding protein, SREBP-1: sterol response element binding protein-1, PYY: peptide
YY, LPS: lipopolysaccharide, NF-kappaB: nuclear factor-kappaB, TNF-𝛼: tumour necrosis factor alpha, mRNA: messenger RNA, GPR41 and GPR43: G protein
coupled receptors 41 and 43, SCFA: short chain fatty acid, and eCB: endocannabinoid.
2.2. Gut Microbiota and Fasting Induced Adipocyte Factor.
Fasting induced adipocyte factor or angiopoitein-like protein
4 (Fiaf /ANGPTL4) is a target gene for peroxisome receptor
activated proteins (PPARs) and is produced by large intestinal
epithelial cells and the liver. Fiaf /ANGPTL 4 inhibits lipopro-
tein lipase (LPL) which causes accumulation of fat in periph-
eral tissues. Inhibition of fiaf by the gut microbiota with a
resultant increase in LPL may be one mechanism for gut
bacterial induced host adiposity [1].This is further supported
by studies on GF mice, genetically deficient in fiaf genes
(fiaf −/−). Lack of the fiaf gene causes disinhibition of LPL
which leads to deposition of up to 60% higher epididymal
fat compared to germ-free wild-type littermates expressing
fiaf genes (fiaf +/+). fiaf /ANGPTL4 is therefore involved in
the regulation of fat storage mediated by the gut microbiota.
Controlled manipulation of the gut microbiota may alter
the expression of this hormone [74]. Normal weight SPF
C57B/6J mice were fed either with high fat (20%) diet or high
fat diet supplemented with probiotic Lactobacillus paracasei
F19 for 10 weeks. Compared to the nonsupplemented group,
plasma fiaf /ANGPTL4 was upregulated in the Lactobacillus
paracasei F19 supplemented group with significantly elevated
plasmaVLDL but no change in other lipoproteins. In another
study, Lactobacillus paracasei F19 and Bifidobacterium lactis
BB12 were found to upregulate ANGPTL4 in the colon
carcinoma HCT116 cell line in a dose and time dependent
manner while Bacteroides thetaiotaomicron had no effect
[74]. In the same study, the authors fed germ-free NMRI
mice with normal chow and exposed them to F19. They
found an increasing trend of ANGPTL4 in the serum after
2 weeks of colonisation, while the effect was not observed
with heat killed F19 [74]. This study suggested that manip-
ulation of expression of fiaf /ANGPTL4 is dependent on the
gut microbiota and future interventional studies on weight
management can be based on modification of ANGPTL4 by
manipulating the gut microbiota.
Whether the increase in levels of fiaf in systemic cir-
culation and the subsequent suppression of LPL and fat
storage is associated with a change in gut microbiota has
been questioned in some studies as there was no difference
in fiaf in serum of GF and conventionally raised mice [14].
GF and CV mice were fed a low fat diet (LF), high fat diet
(HF), and commercial high fat Western diet (WD). GF mice
gained more weight and body fat than CV mice on HF and
vice versa on WD. Although intestinal fiaf /ANGPTL4 was
high in GF mice on HF and WD, circulating levels of fiaf
did not change significantly compared to CV mice. The gut
microbiota changed differently with HF andWD in CVmice.
These observations suggested that diet affects the type of gut
microbiota in the gut and that fiaf does not play a major role
in peripheral fat storage as mentioned by other studies.
2.3. Gut Microbiota and Fatty Acid Oxidation. The gut
microbiota are thought to reduce muscle and liver fatty acid
oxidation by suppressing adenosine monophosphate kinase
(AMPk), an enzyme in liver and muscle cells that acts as
4 Journal of Obesity
Table 2: Studies looking at differences in SCFA in faecal or caecal samples in obese versus lean phenotypes in animal and human studies.
Reference Technique used SCFA differences Gut microbiota differences




↑ caecal acetate and ↑ butyrate in obese
ob/ob mice compared to lean
↑ Firmicutes and lower Bacteroidetes in obese
than lean mice. No differences in genera level
diversity




↑ acetate in obese compared to lean and
gastric bypass group
↑M. smithii and Prevotellaceae in obese
compared to lean and gastric bypass
Schwiertz et al. 2010
[18]
GC and qPCR with
SYBR Green
↑ total SCFA and propionate (conc. & %) in
obese compared to lean
↑ Bacteroides and ↓ Firmicutes, ↓ Ruminococcus
flavefaciens, ↓ Bifidobacterium, and
↓Methanobrevibacter in obese compared to
lean




↑ butyrate, propionate, and isobutyrate in
obese compared to lean
↑ lactate and valerate in lean compared to
obese
No difference in acetate and total SCFA
No difference in Firmicutes and Bacteroidetes,
Firmicutes/Bacteroides ratio, Bifidobacteria,
Enterobacteriaceae, and sulphate reducing
bacteria between lean and obese children
↑ Roseburia/E. rectale in obese
Highly variable banding pattern on TGGE for
both obese and healthy
Yang et al. 2013
[25] GC
↑ ratio of molar propionate: total SCFA and
↓ acetate : SCFA ratio in obese versus lean Not measured
Teixeira et al. 2013
[26] GC
↑ acetate, propionate, and butyrate in obese
versus lean women
SCFA correlated with body fat, blood
pressure, waist circumference, insulin, and
HOMA index
Not studied
Belobrajdic et al. 2012
[27] GC
Increase in total SCFA pool and stool energy
irrespective of obese or lean phenotype
(obesity prone or obesity resistant) in
response to 0, 4, 12, and 16% resistant starch






↑ total SCFA, acetate, and butyrate in obese
compared to lean
No differences in isobutyrate, isovalerate,
and valerate
↑ Firmicutes : Bacteroidetes ratio in obese.
Firmicutes correlated with SCFA in obese
Fernandes et al. 2014
[29] GC, qPCR
Significantly ↑ propionate and valerate
Marginally ↑ acetate and butyrate
Escherichia Coli higher in lean than obese
No difference in Bacteroides/Prevotella,
Clostridium coccoides and C. leptum group,
Bifidobacteria, and total bacteria, F/B ratio
Li et al. 2013
[30] GC Higher SCFA in obese than lean ↑ Firmicutes and lower Bacteroidetes in obese
GC: gas chromatography, GC-MS: gas chromatography-mass spectrometry, SPME-GCMS: solid phase microextraction-gas chromatography mass spectrom-
etry, v1-v2: variable regions 1 and 2, HPLC: high performance liquid chromatography, TGGE: temperature gradient gel electrophoresis, CHO: carbohydrate,
EU: European Union, qPCR: quantitative polymerase chain reaction, and F/B ratio: Firmicutes to Bacteroidetes ratio.
a fuel gauge monitoring cellular energy status. Inhibition of
AMPk results in reducedmuscle and liver fatty acid oxidation
ultimately leading to excess fatty acids storage in these tissues
[1].
Phosphorylated AMPk inhibits the formation of malonyl
CoA via acetyl CoA carboxylase. Inhibition of malonyl CoA
causes disinhibition of carnitine palmitoyltransferase-1 (Cpt-
1) which in turn catalyses the rate limiting step in the entry
of long chain fatty acyl-CoA into mitochondria for fatty acid
oxidation [75]. Increased fatty acid oxidation is associated
with enhanced cellular energy status coupled with glycogen
level reduction and increased insulin sensitivity [75].
Germ-free mice have a consistently raised level of phos-
phorylated acetyl CoA carboxylase (Acc) and carnitine
palmitoyltransferase-1 (Cpt-1) activity in gastrocnemiusmus-
cles and raised AMPk in liver and skeletal tissue compared
to CONV mice [13, 76]. This effect has also been observed
with high calorie diet suggesting that enhanced or suppressed
muscle fatty acid oxidation is dependent on the presence or
absence of gut microbiota. The gut microbiota may therefore
influence storage of peripheral adipose tissue and hence host
adiposity by inhibiting fatty acid oxidation.
2.4. Gut Microbiota and Bile Acids Circulation. Primary bile
acids (cholic and chenodeoxycholic acids) are ligands for the
farnesoid x receptor (FXR) which plays a key role in the con-
trol of hepatic de novo lipogenesis, very low density lipopro-
tein (VLDL) triglyceride export, and plasma triglyceride
turnover leading to improved lipid and glucose metabolism
[6]. By binding to FXR in ileal cells, bile acids are able to
stimulate the expression of genes (Asbt, IBABP, and Ost
𝛼/𝛽) which help in absorption, intracellular transport, and





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1: Modulation of bile acid circulation by gut microbiota
and its effect on glucose metabolism. Concept adapted from [6–
8]. TGR5: G protein coupled receptor 5, VLDL: very low density
lipoprotein, TG: triglycerides, GLP-1: glucagon like peptide-1, and
FXR: farnesoid x receptor.
systemic transport of bile acids into the liver by enterohepatic
circulation (Figure 1). Study on germ-free and FXR deficient
mice suggests that the expression of genes responsible for the
uptake, transport, and export of bile acids into circulation
after ileocaecal resection is dependent on gutmicrobiota [19].
Primary bile acids entering the large intestine are converted
to secondary bile acids (deoxycholic and lithocholic acids)
by gut microbiota. Secondary bile acids are ligands for G
protein coupled receptor 5 (TGR5) which helps in glucose
homeostasis by stimulating the expression of glucagon like
peptide-1 (GLP-1) and reduces serum and hepatic triglyceride
levels [7, 8]. Gut microbiota may therefore affect host hepatic
adiposity by altering bile acid circulation via FXR and TGR5
mechanisms. However, it is also suggested that bile acids may
reciprocally cause dysbiosis through their bactericidal activ-
ity by damaging the microbial cell membrane phospholipid
[77]. Furthermore, high saturated fat but not polyunsaturated
fat promotes the expansion of pathobionts such as Bilophila
wadsworthia and activates proinflammatory markers such as
IL-10 causing experimental colitis [78].
2.5. GutMicrobiota and Changes in Satiety (Gut-Neural Axis).
The gut microbiota, through production of SCFA, may affect
host energy metabolism and development of obesity by
changing the hormonal milieu in the intestine and other
visceral organs (Figure 2). Glucagon like peptide-1 (GLP-1)
plays a key role in regulating communication between the
nutritional load in the gut lumen and peripheral organs such
as brain, liver, muscle, and adipose tissue by postprandial
increases in satiety, gut transit time, and incretin induced
insulin secretion [79]. Secretion of GLP-1 is decreased in
obesity secondary to weight gain which causes insulin resis-
tance independent of circulating level of fatty acids [79]. The
gut microbiota regulate GLP-1 by influencing the expression
of its precursor, proglucagon, and increasing GLP-1 positive
enteroendocrine L-cell in the gut [80]. Dietary fibres (nondi-
gestible and fermentable fibres), as well as SCFA, have been
shown to increase GLP-1 secretion in both human [81] and
animal studies [82].Mice lacking receptors for the attachment
of SCFA (GPR43 and GPR41 deficient mice) showed in vitro
and in vivo reduced GLP-1 secretion and impaired glucose
tolerance [83].
SCFA including acetate, propionate, and butyrate act as
ligands for the activation of G protein coupled receptors
43 and 41 (GPR41 and GPR43) which are expressed by gut
epithelial cells, endocrine cells, and adipocytes. GPR43 in
white adipose tissue act as sensors of postprandial energy
excess and regulate energy expenditure and hence body
energy homeostasis. GPR43 and GPR41 enhance insulin
sensitivity and activate the sympathetic nervous system at
the level of the ganglion to prevent excess energy deposition
in adipose tissue and enhance energy expenditure in other
tissues such as liver and muscles [22]. GPR43 deficient mice
have metabolic abnormalities including excess fat accumu-
lation. When treated with antibiotics or under germ-free
conditions, these metabolic abnormalities reverse suggesting
that the gut microbiota are key players in expression of these
receptors [22]. Samuel et al. (2008) demonstrated that GF
mice deficient in GPR41 genes remain lean compared with
their wild type counterparts, although their body composi-
tion was not different [84]. They also showed that GPR41
stimulates the expression of the gut anorexigenic hormone,
peptide YY (PYY), which in turn causes inhibition of gastric
emptying, reduced intestinal transit time, increased energy
harvest (in the form of caecal acetate and propionate), and
increased hepatic lipogenesis [84].
Bifidobacteria are inversely associated with the devel-
opment of fat mass, glucose intolerance, and bacterial
lipopolysaccharide (LPS) in the blood via SCFA-induced
stimulation of PYY and ghrelin. Intervention with prebi-
otics such as dietary fructans or oligofructose stimulates
bifidobacterial growth [76] and reduces weight accompanied
by increased PYY and reduced ghrelin consistent with a lower
food intake in the prebiotics group [85]. Intervention with
16 g fructose/day or 16 g dextrin maltose/day for 2 weeks in
a randomised control trial was associated with an increase
in breath hydrogen (a marker of colonic fermentation) and
increased production of PYY and GLP-1 [86].
Overall, this evidence suggests that alteration in the gut
microbiota may affect hormonal status via GLP-1 and G
protein coupled receptors. These hormonal changes bring a
change in satiety, food intake, and overall metabolic status of
an individual that could affect host adiposity. Whether this
relationship is causal needs further investigation.
2.6. Gut Microbiota and Intestinal Permeability: Chronic Low-
Grade Inflammation. Emerging evidence suggests close ties
















↑ TG storage in
Figure 2: Proposedmechanism of the changes in gut hormonal axis by gut microbiota. TG: triglycerides, LPL: lipoprotein lipase, Fiaf: fasting
induced adipocyte factor, ANGPTL-4: angiopoitein-like protein-4, GLP-1: glucagon like peptide-1, GPR43 and GPR41: G protein coupled
receptors 43 and 41, PYY: peptide YY, and SCFA: short chain fatty acids. Minus sign indicates inhibitory effect; plus sign indicates stimulatory
effect.
between metabolic and immune systems [11]. Obesity con-
tributes to immune dysfunction by secretion of inflammatory
adipokines from adipose tissues such as TNF-𝛼, IL-6, and
leptin [87]. Inflammatory adipokines induce carcinogenic
mechanisms such as increased cellular proliferation and/or
dedifferentiation that are potential risk factors for cancers
such as colonic, oesophageal, and hepatocellular cancers. An
example of this is the association of high levels of leptin
with hepatocellular carcinoma [87]. Intra-abdominal adipose
tissue secretes adipokines with atherogenic properties (IL-1,
IL-6, TNF-𝛼, and IFN-𝛼) which increase the risk of cardio-
vascular diseases [88].These proinflammatory cytokines also
activate certain kinases, which in turn initiate the expression
of inflammatory and lipogenic genes, ultimately increasing
inflammation and adipogenesis in a loop fashion (Figure 3).
2.6.1. Bacterial Lipopolysaccharide (LPS) and Inflammation.
The gut microbiota may contribute to chronic low-grade
inflammation and obesity via the absorption of bacterial LPS,
an outer membrane component of Gram negative bacteria,
which is increasingly recognized as a player in chronic low-
grade inflammation, a hallmark of obesity.
Cani et al. (2007) demonstrated the link between LPS and
metabolic disease by infusing bacterial LPS subcutaneously
into germ-free mice for 4 weeks which produced the same
level of metabolic endotoxemia as by high fat diet [9].
Furthermore, mice lacking functional LPS receptors were
resistant to these changes. Feeding high fat diet to mice with
mucosal immune dysfunction (Toll-Like Receptor-4 knock-
out mice) for 4 weeks resulted in two to three times increased
systemic LPS levels in liver, adipose tissue and muscles, and
higher body fat mass, termed as “metabolic endotoxemia”
[9]. This inflammatory status was associated with lower Bac-
teroides, Bifidobacterium species, and Eubacterium rectale-
C coccoides group [9]. Additionally, LPS stimulated markers
of inflammation (e.g., plasminogen activator inhibitor 1 and
tumour necrosis factor alpha) and oxidative stress (e.g., lipid
peroxidation) in visceral adipose tissue via the CD14 receptor.
Absence of CD14 in CD14 deficient ob/ob (CD14 −/−) mice
has been shown to protect against diet induced obesity and
inflammation in mouse models [10].
2.6.2. Gut Barrier Integrity and Inflammation. Alteration
in the gut microbiota is linked to changed gut barrier
function [10] and may promote the release of bacterial
endotoxins through damaged and leaky gut. Cani et al.
(2007) showed a significant reduction in Bifidobacteria with
high fat diet in male C57BL/6J mice [76]. Supplementation
with oligofructose was shown to restore the Bifidobacteria
population with improvement in gut barrier function evi-
denced by the expression of precursors ofGLP-1, proglucagon
mRNA, and decrease in endotoxemia [76]. No correlation
was found between endotoxemia and other bacteria (Lac-
tobacilli/Enterococci, E. rectale/C. coccoides, Bacteroides, and
sulphate reducing bacteria) [76]. GLP-1 helps in the differen-
tiation of mucosal cells into enteroendocrine L-cells, while
GLP-2 helps in increased expression of mRNA for synthesis
of tight junction proteins. These changes are associated with
lower LPS in the blood suggesting increased integrity of the
gut barrier function. In contrast treatment with antibiotics
reduced inflammation by reducing the LPS-producing gut
microbiota population, further elucidating the relationship
between gut microbiota, LPS levels, and inflammation [10].
2.6.3. High Fat Diet and Inflammation. The association of
high fat diet with subclinical or clinical inflammation in
obesity has been investigated in several studies and there
is a clear evidence to suggest that consumption of high
fat diet is associated with metabolic endotoxemia and 2-
3-fold increase in bacterial LPS levels in the blood [9].
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Figure 3: Proposed model for the role of LPS in generating inflammation and its relationship with obesity. Concept adapted from [9–
12]. Altered mucosal barrier function due to reduced expression of glucagon like peptides 1 and 2 (GLP-1 and GLP-2) leads to altered
mucosal function and reduced synthesis of tight junction proteins, Zonula Occludin-1 and Zonula Occludin-2 (ZO-1, ZO-2), increasing gut
permeability.This allows LPS to enter the systemic circulation inducing the release of proinflammatory cytokines. Proinflammatory cytokines
result in activation of a family of kinases JNK and IKK (inhibitor of NFkB kinase) that increase the expression of inflammatory and lipid
metabolism genes. Subcutaneous administration of LPS, hyperglycaemia, and insulin resistance induces the same pathway by increasing the
endoplasmic reticulum and mitochondrial stress. Type-2 diabetes, hyperglycaemia, and insulin resistance also cause macrophage infiltration
and inflammatory cytokine release leading to the same process. HF: high fat diet [9–12].
However, it is controversial whether this chronic low-grade
inflammation is dependent on the gut microbiota. Cani et al.
(2007) found a dramatic change in gut microbiota (reduced
Lactobacillus, Bacteroides/Prevotella, and Bifidobacteria) of
obese ob/ob mice fed high fat diet [76]. This was associated
with an increase in gut permeability indicated by a reduced
expression of Occludin and ZO-1 tight junction proteins.
In contrast, de la Serre et al. (2010) suggested that high
fat diet induced intestinal inflammation in obese Sprague-
Dawley rats may cause hyperphagia and obesity by impairing
the regulation of food intake. However, changes observed
in the gut microbiota were independent of lean and obese
phenotype [15]. High fat diet for 8 or 12 weeks in Sprague-
Dawley rats revealed two genetically distinct groups, diet
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induced obesity resistant (DIO-R) rats which were resistant
to diet induced obesity and diet induced obesity prone (DIO-
P) rats, which were prone to diet induced obesity on feeding
high fat diet. DIO-P rats had significantly increased gut
permeability, increased LPS levels, lower intestinal alkaline
phosphatase (iAP) levels (which detoxifies LPS), and systemic
inflammation (high Toll-Like Receptor-4/Mitogen Detector-
2 protein immunoreactivity) compared to DIO-R [15]. Acti-
vation of TLR4 by LPS via MD-2 results in the production of
an inflammatory cascade (IL-6 and TNF alpha) [89] ensuing
metabolic endotoxemia. Mice with genetic deficiency of
TLR4 do not develop diet induced obesity [34]. This series of
changes associated with high fat diet inducing inflammation
may alter food intake regulation and trigger hyperphagia, the
mechanism of which is yet to be fully understood.
2.7. Gut Microbiota and Endocannabinoid Receptor System.
Cannabinoid receptors 1 and 2 (CB1 and CB2) are G proteins
activated by the endocannabinoid (eCB) system. The eCB
system is composed of endogenous lipids and plays an
important role in adipogenesis, as studied in genetically
obese mice models. Two of the most widely studied lipids
in the eCB system are N-arachidonoylethanolamine and
2-arachidonoylglycerol. The level of eCB components is
inversely related to obesity and type-2 diabetes as both the
conditions are associated with a higher tone of eCB system.
Furthermore, the expression of CB1 and CB2 degrading
enzymes (fatty acid amide hydrolase) is increased in adi-
pose tissue of obese ob/ob mice compared with lean mice
[10].
Bacterial LPS regulates the expression of cannabi-
noid receptors via the LPS receptor signalling system
shown in both in vitro and in vivo studies [90]. This
increased tone is represented by higher levels of the pre-
cursor enzymes N-acylphosphatidylethanolamine-selective
phospholipase-D, CB1 mRNA, and increased eCB compo-
nents in plasma or adipose tissue [90]. Using CB1 receptor
antagonists in ob/ob obese mice with disrupted gut barrier
and metabolic endotoxemia improves gut permeability and
reduces body weight, compared with lean littermates [90].
The gut microbiota therefore regulate the activity of the eCB
system and play an important role in host energy regulation.
A study by Geurts et al. (2011) in obese leptin resistant
db/db mice suggested that the abundance of Gram negative
bacteria, higher Firmicutes and Proteobacteria, and lower
Bacteroidetes were correlatedwith upregulation of apelin and
APJ expression. This was shown to be the result of direct
action of bacterial LPS on the expression of apelin and APJ
mRNA in obese diabetic mice through chronic low-grade
inflammation [20]. These newly discovered adipokines are
widely expressed in mammalian tissues. Apelin is a ligand
for APJ, a G protein coupled receptor. Apelin/APJ system
plays a key role in the cardiovascular system by acting on
heart contractility, blood pressure, fluid homeostasis, vessel
formation, and cell proliferation. Apelin also affects glucose
homeostasis by acting through AMP kinase and nitric oxide
(NO) dependent mechanisms [91]. Endocannabinoid system
downregulates the expression of apelin and APJ mRNA in
physiological conditions. In contrast, higher levels of apelin
and APJ mRNA have been found in pathological conditions
such as obesity and diabetes [20].
In summary, bacterial LPS increase the tone of eCB
system and increase the expression of apelin/RPJ system in
adipose tissue. However, how far gut microbiota population
contribute to the actions of eCB and apelin/APJ and eCB
in obesity is unknown. This has opened yet another area of
interest in the role of gut microbiota in obesity.
3. Review of Animal Studies Relating Gut
Microbiota with Obesity
The evidence from animal studies has thus far concen-
trated on studies which looked at the interplay of diet,
gut microbiota, and metabolic changes (in energy balance,
lipoproteins, cholesterol, etc.) in animal models such as wild-
type mice, leptin deficient ob/ob mice, and Sprague-Dawley
rats. Initial evidence suggesting a strong association of the
gut microbiota with obesity was explored in a series of
studies using germ-free and CONVmice. Components of gut
microbiota acting as triggers in the development of obesity
[40] and the emergence of diet induced obesity prone (DIO-
P) mice and diet induced obesity resistant (DIO-R) mice fed
on the same high fat diet [92] suggested that the peculiar
compositional differences alter the host response to prioritise
its metabolism towards increased energy harvest. Phylum
level compositional differences in the relative proportions of
the gut microbiota were therefore seen (Table 3) [1, 3, 4]
and despite differences at species and genera level between
studies, there is a general agreement on reduced diversity and
richness of the gut microbiome in obese versus lean animals.
However the gut microbiota are located at the interface
of environment and host. The effect of environmental factors
particularly diet may therefore be highly significant and
contribute to changes in the gut microbiota composition
and function and ultimately their phenotype (obese or lean
microbiome) [36]. Ingestion of high fat Western diets may
play an important role in modifying the gut bacterial popu-
lation which in turn alters the energy harvesting capability.
This has been studied in various animal models such as
GF/CONV mice and Sprague-Dawley rats [15, 17], leptin
deficient ob/obmice models [31], and immune deficient mice
models (Toll-Like Receptor proteins deficient mice) [40]
showing a tendency towards an increase in populations of
Firmicutes and reduction in Bacteroidetes after feeding with
high fat Western diet.
Furthermore, observations from studies on GF/CONV
mice and Sprague-Dawley rats suggest that a high fat diet,
especially HF Western diet, is associated with increased
adiposity, reduced bacterial diversity [17], reduced number
of Bacteroides, a relative increase in favour of Firmicutes
[17], and higher jejunal alkaline phosphatase activity [31].
Moreover, high fat diet correlates with changes in inflamma-
tory markers and oxidative stress [10] such as tumour necro-
sis factor alpha (TNF-𝛼) and nuclear factor-kappaB (NF-
kappaB), which play a major role in promoting inflammation
[93], immune response, cellular proliferation, and apoptosis.
In CONV mice, but not in germ-free mice, changes in the
14 Journal of Obesity
expression of these inflammatory markers in the intestine
preceded weight changes and carried a strong positive cor-
relation with high fat diet induced adiposity and markers of
insulin resistance [32].This suggests an interaction of high fat
diet and enteric bacteria-promoting intestinal inflammation
and insulin resistance prior to weight gain which is driven by
the high fat diet.
Studies in leptin deficient ob/ob mice, genetically prone
to obesity, indicated that although the obese phenotype is
characterised by a particular set of gut microbiota, change
in caloric load and diet redistributes the equilibrium that
may be independent of the genotype or phenotype (obese or
lean) [16]. Changes in gut microbiota composition may be
attributed to the high fat diet rather than genetic propensity to
obesity. Furthermore, shift towards higher Firmicutes to Bac-
teroidetes or the absence of gutmicrobiotamay not be associ-
ated with the development of obesity [14]. The assertion that
germ-free mice are protected from obesity was contradicted
by Fleissner et al. (2010) where GF had a significantly higher
body weight gain than CONV mice on high fat diet despite
increased Firmicutes (specifically, Erysipelotrichaceae) at the
expense of Bacteroidetes in CONV on a high fat diet and
Western diet [14].
Faecal transplantation studies support the causal role
of the gut microbiota in the aetiology of obesity. Trans-
plantation of gut bacteria from obese human twins to lean
mice caused not only obesity but also a higher number
of genes involved in detoxification and stress response,
biosynthesis of cobalamin, essential and nonessential amino
acids, and gluconeogenic pathways. In contrast, animals
with lean-transplanted microbiota exhibited genes capable
of fermenting plant polysaccharides and producing butyrate
and propionate [94]. Additionally, the mere presence of
the gut microbiota in conventionally raised mice has been
shown to result in higher levels of energy metabolites such
as pyruvic, citric, fumaric, and malic acid and higher rate of
clearance of cholesterol and triglycerides than in germ-free
mice [95]. This suggests that the gut microbiota are essential
for the characteristic pattern of metabolites in the gut of a
species [96]. In postgastric bypass animals, gut microbiota
transplanted from a postgastric bypass animals who lost
weight after surgery were associated with weight loss and
other metabolic changes in recipient obese mice with no
surgery [97].
It is however interesting to observe that lean animals
cohoused with obese cage mates are reported to develop
obesity and obesity related microbiota and metabolism in
some studies [17] but not others [94] although themicrobiota
and metatranscriptome of obese animals became similar
to the lean phenotype suggesting a “functional transforma-
tion” [94]. As discussed above, the functional association of
metabolic endotoxemia with gut microbiota was dependent
on a high fat diet in the obese ob/ob animal model [10, 76].
However, these effects were later shown to be independent of
obesity phenotype, as a high energy intake in lean C57BL/6J
mice fed a high fat diet produced a 2-3-fold increase in
plasma LPS compared to normal chow diet. Furthermore, the
increase was blunted when the percentage intake of energy
contributed by fat was reduced [98]. de Wit et al. (2012)
showed that a high fat diet composed of palm oil (with
more saturated fat) distinctly increased the Firmicutes to
Bacteroidetes ratio in the gut compared to a diet high in fat-
olive oil, high fat-safflower oil, and low fat-palm oil [35]. High
fat-palm oil also stimulated expression of 69 genes related to
lipidmetabolism in the distal intestine suggesting an overflow
of lipids to the distal small intestine resulted in enhanced lipid
metabolism and changes in gut microbiota.
Several other studies suggested similar changes in gut
microbiota and the presence of genes for lipid metabolism in
animal models using different dietary regimens [37, 38, 99]
(Table 2). Daniel et al. (2014) investigated composition and
function of gut microbial ecology after 12 weeks of high fat
diet (HF) or high carbohydrate (CARB) diet [33]. Diets, and
not the gut microbiota, were shown to affect not only the
distribution of the gut microbiota communities (decrease
in Ruminococcaceae and increase in Rikenellaceae with HF
compared to CARB) but also the metabolome and proteome
of the individual groups [33]. Although this study used two
functional approaches to explore gutmicrobiota function, the
numbers were very low (𝑛 = 3) whichmight have contributed
to variation within the groups.
3.1. Conclusion from Animal Studies. In conclusion, the rela-
tionship of gut microbiota with diet and metabolic disorders
has been studied in a variety of animal models. There is
controversy as to whether these changes are attributable to
the diet itself or are caused by the gut microbiota. Studies
in germ-free mice suggest the gut microbiota are the critical
player in inflammation, development of immunity, and host
metabolic regulation. However, diet is also considered a con-
founding factor that determines a change in gut microbiota
and obesity because the diversity of gut microbiota has not
been found to be different between wild-type and certain
genetic models of obese mice.
Discrepancies between and within studies could be
attributed to the selection of animals (rats versus mice)
and individual strains. A recent study by Walker et al.
(2014) observed a distinct microbiome and metabolome in
two strains of C57BL/6J and C57BL/6N mice [100]. Some
differences in the metabolome might also be attributed
to gender [96] and described above in addition to other
methodological, host, and environmental differences. The
exactmechanismof how these changes lead to an obesity phe-
notype is still not known. Large humans based interventional
studies are therefore required to establish the true association
between diet and gut microbiota and obesity.
4. Review of Human Studies Relating Gut
Microbiota with Obesity
Evidence linking the gut microbiota with obesity in humans
is thus far inconclusive and controversial. This may be
partly due to marked interindividual variations in the gut
microbiota and metabolic activity in humans with age, diet,
use of antibiotics, genetics, and other environmental factors
[101]. Apart from the interindividual variation in faecal
microbiome and diversity, reanalysis of large datasets such as
from the human microbiome project (HMP) and MetaHIT
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Table 4: Association of gut microbial species/genera with obesity or leanness in human studies.
Bacteria Association∗ with obesity Group Level Other associations Reference
Lactobacillus reuteri +ve Firmicutes Species — [44, 45]
Clostridium cluster XIVa +ve Firmicutes Group Anti-inflammatory [46]
E. coli +ve Proteobacteria Species Nonalcoholic steatohepatitis (NASH) [46]
Staphylococcus spp. +ve Firmicutes Genus Energy intake [47]
Bacteroides −ve/+ve Bacteroidetes Genus Controversial [5]
Akkermansia muciniphila −ve Verrucomicrobia Species Mucus degradation [42]
Methanobrevibacter smithii −ve Archaea Species Increase in anorexia [48]
Clostridium cluster IV; F. prausnitzii −ve Firmicutes Species Anti-inflammatory [49]
Bifidobacteria −ve Actinobacteria Genus −ve association with allergy [44]
∗Associations based on correlation or regression analysis or statistically significant differences between the lean and obese. +ve: positive association, −ve:
negative association, and +ve/−ve: controversial.
has shown interstudy variability which was far greater than
the actual differences between the lean and obese phenotypes
[102]. Refined statistical modelling therefore led to loss of
some correlations previously found, such as between BMI
and Firmicutes to Bacteroides ratio [102]. Bridging these gaps
in analysis and accounting for these technical and clinical
factors is therefore important to elucidate differences between
normal and altered host microbiome and metagenome.
The first evidence showing higher Firmicutes and lower
Bacteroidetes in obese versus lean adults before the onset
of dietary intervention was presented by Ley et al. (2006)
[5], followed by a number of studies reviewed in Table 6.
Moreover, several gut microorganisms have been associated
with obesity or leanness [44, 103] (Table 4). The type of
gut microbiota and their exact phylogenetic level at which
they exhibit differences are still under investigation. Evidence
suggesting no phylum level differences between lean and
obese gut microbiota [18, 65] may indicate that functionality
of bacteria may play a more important role than particular
bacterial groups.
The energy harvesting capability of the gut microbiota
in obese subjects is thought to be set at a higher threshold
than in the lean with or without differences in the relative
abundance of the gut microbiota. Obese adults had higher
individual and total SCFA than lean adults in the absence
of any difference in the relative abundance of major gut
bacterial phyla [29]. Moreover, no significant correlation of
the gut microbiota with dietary factors in early [59] and
later childhood [47] and a positive correlation with BMI
SDS indicate that changes in the gut microbiota at these
developmental stages may not depend on dietary factors.
On the other hand, evidence also suggests that diet
plays an important role in altering the proportion of gut
microbiota in individuals because the amount and type
of bacteria change significantly with diet [64, 67]. This
varies between individuals and may be due to the distinct
microbiota colonisation during early life, altering the capacity
for energy harvest from the diet. Composition and caloric
content of the diet significantly alter the relative abundance
of the gut microbiota [67]. An increased intake of resistant
starch was associated with an increase in Eubacterium rectale
(a butyrate producing bacteria) to ∼10% and Ruminococcus
bromii (an acetate producer) to ∼17% compared with ∼4%
in volunteers consuming nonstarch polysaccharides [67].
These changes were reversed with weight loss diets along
with a decrease in Collinsella aerofaciens, a member of
Actinobacteria.This shows the substantial effect of diet on the
gut microbiota and its energy harvesting capability [64, 67].
Similarly, SCFA production is affected by nutrient load and
dietary carbohydrate available for fermentation. Weight loss
diets usually have low carbohydrate and high protein content
and reduce the population of butyrate producing Roseburia
and Eubacterium rectale [66].
Long term changes in gut microbiota (such as lower
counts of Bifidobacteria and higher Bacteroides) have been
observed in children who were exposed to antibiotics in
early childhood [104, 105]. Modulation of gut microbiota
with antibiotics (e.g., norfloxacin and ampicillin) alters
the expression of hepatic and intestinal genes involved in
inflammation and metabolism thereby changing the hor-
monal, inflammatory, and metabolic milieu of the host [106].
These antibiotic induced changes may predispose children to
overweight and obesity by promoting “obesogenic-bacterial-
growth” (Table 5). The development of gut microbiota in
infants and their tendency towards overweight and obesity
in later childhood are linked to mother’s prepregnancy BMI
and gutmicrobiota with significantly lower numbers of faecal
Bifidobacteria and Bacteroides and significantly higher E.
coli and Staph. aureus in overweight and obese compared to
normal weight pregnant women [64].
In addition to compositional differences between lean
versus obese subjects [5], functional differences in the
metabolome of the obese and lean phenotype may be more
important. Calvani et al. (2010) in their preliminary study
of 15 morbidly obese and 10 age matched controls found
distinct gut microbial cometabolites in urine of obese versus
lean participants, including lower levels of hippuric acid
(benzoic acid derivative), trigonelline (niacin metabolite),
and xanthine (purine metabolism) and higher levels of 2-
hydroxybutyrate (metabolite of dietary protein) [49]. The
metabolic or functional representation of gut microbiota
might be proportional despite differences in the relative
abundance of the gut microbiota. Disturbance of this equi-
librium is a hallmark of the obese phenotype as suggested
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by Ferrer et al. (2013) in a comparative metagenomic and
metatranscriptomic analysis of faecal samples from obese
and lean adolescents [61]. Despite low compositional repre-
sentation (up to 18%), up to 81% of the expressed proteins
were contributed by Bacteroidetes [61]. Moreover, the obese
metagenome had higher aerobic and anaerobic vitamin
B12 and 1,2-propanediol metabolism genes than the lean
which expressed genes related to vitamin B6 metabolism
[61]. A recent study by Cottilard et al. (2013) has shown
a reduced bacterial richness, reduced diversity, and higher
dysmetabolism and low-grade inflammation in obese versus
lean humans [71]. Although dietary intervention partially
improved gene richness, reduced measures of adiposity such
as waist circumference and fat mass, and reduced plasma
cholesterol, it was less efficient in improving low-grade
inflammation [71]. Furthermore, the tendency of the changes
in gene clusters to return to the predietary restriction phase
suggests that gut microbiota remain stable in individuals
after the dietary stimulus is removed. Similarly, postgastric
bypass surgery changes in gut microbiota and the expression
of genes in obese subjects tend to reverse in the long term
suggesting restructuring of the gut microbiota and a plateau
of the response to changes in gut physiology [45]. Probiotics
(such as L. paracasei strain F19) may beneficially affect
short term energy homeostasis in weaning infants [107].
However, no differences in serum lipids, glucose, insulin,
and anthropometry were seen in the F19 intervention group
compared to placebo groupwhen the same cohort of children
were followed up at age of 8-9 years [108].
In this context, factors affecting colonisation of the gut
microbiota in the newborn from before birth to early and
late childhood might play an important role. However, the
role of these factors in establishing a gut microbiota with
tendency towards obesity or allergic disorders in later life is
controversial. For example, higher numbers of Bifidobacteria
and lower numbers of Staphylococci in breast fed children
at age of 6 and 12 months had a negative correlation with
overweight and obesity at 7 years [53]. Similarly, population
based cohort study of a DanishNational Birth Cohort did not
show association of caesarean section with the development
of overweight and obesity in more than 10,000 male children
[51]. However, despite a larger cohort, the data was not
adjusted for other confounding factors such as socioeco-
nomic status and anthropometric and behavioural factors. In
contrast, a recent Brazilian study following children born by
caesarean section (𝑛 = 5914) at age of 4, 7, 15, and 23 years
showed that although children born with caesarean section
had ∼50% higher prevalence ratio of obesity, this effect
was lost when adjusted for socioeconomic, demographic,
maternal, anthropometric, and behavioural factors [109].
4.1. Conclusions from Human Studies. Controversies exist as
to whether or not obese and nonobese individuals host a
particular type of bacterial phyla or enterotype and whether
the response of the gut microbiota to diet differs. Correlation
of BMI with Bacteroides in obese and nonobese subjects
on different dietary regimens [65] is unclear as an inverse
relationship has also been observed [18], adding to the
complexity of the relationship of diet, gut microbiota, and
obesity. The population of gut microorganisms in the human
intestine is affected by a variety of factors from birth till
adulthood, of which some are known and others are largely
unknown. Additionally, large interindividual variations have
been observed in all human studies suggesting host diet
interaction at individual level.
5. Conclusion
The prevalence of obesity has increased in pandemic pro-
portions in adults and children. Several factors have been
identified to explain the aetiology and pathogenesis of obesity
including diet, lifestyle, environmental factors, and host
genetic factors. However, none of these fully explain the
aetiology of obesity and the search for possible causes con-
tinues. The gut microbiota have been advocated as one factor
affecting host energy homeostasis through several putative
mechanisms investigated in mice models and human studies.
However, several studies have suggested a profound effect of
diet on the gut microbiota which modify host metabolism
towards a lean or obese phenotype.
The evidence linking gut microbiota to the increasing
epidemic of obesity is too contradictory and inconclusive
to prove a “cause or effect” relationship. This may be due
to differences in methodology, study design, control of diet,
genetic propensity of individuals to obesity, and other lifestyle
factors. Moreover, faecal samples are the usual source of gut
microbiota which may not represent the true picture of the
colonic microbial population. Access to the full length of the
gut is restricted for medical or ethical reasons. In addition,
differences between animals and human beings including
intestinal microbiota, metabolic rate, and length of intestine,
caecal fermentation, coprophagy, and genetic variability limit
the extrapolation of results from animal studies.
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